No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BSX241213P92000
- 1.90
- -0.31-14.03%
15min DelayClose Dec 10 16:00 ET
1.90High1.90Low
1.90Open2.21Pre Close3 Volume47 Open Interest92.00Strike Price570.00Turnover27.75%IV0.11%PremiumDec 13, 2024Expiry Date1.80Intrinsic Value100Multiplier2DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.8030Delta0.1374Gamma45.10Leverage Ratio-0.1097Theta-0.0041Rho-36.22Eff Leverage0.0204Vega
Intraday
- 5D
- Daily
News
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $98
Boston Scientific's Promising Clinical Trials and Innovative Approaches Justify Buy Rating
Boston Scientific Is Maintained at Buy by Canaccord Genuity
Unusual Options Activity: BABA, ADT and Others Attract Market Bets, BABA V/OI Ratio Reaches 120.0
EST Dec 9th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
CCORF Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $101
Express News | Boston Scientific Corp : Canaccord Genuity Raises Target Price to $101 From $98